Rejoint, an innovative Bologna-based startup specializing in customized knee prosthetics, raised €1.35 million from IAG business angels and Doorway community investors to enhance its market presence and refine its technology.

Target Information

Rejoint is an innovative startup based in Bologna, Italy, specializing in the development of customized knee prosthetics. Recently, the company successfully secured a €1.35 million investment round from the business angels of IAG and community investors via the online equity investment platform, Doorway. Rejoint addresses a critical issue in orthopedic medicine, where over 20% of patients undergoing knee prosthetic surgeries express dissatisfaction due to various complications that impact their quality of life, such as pain, inflammation, and size mismatches.

The technological solutions offered by Rejoint are disruptive. Their approach employs augmented reality, artificial intelligence, advanced 3D printing technology, and big data integration through sensor-enabled braces to enhance patient monitoring and improve rehabilitation outcomes. This personalized device design is aimed at significantly improving patient experiences in knee surgery.

Industry Overview of Orthopedics in Italy

The orthopedic industry in Italy is mature and continuously evolving, driven by advancements in technology and an increasing aging population that demands better healthcare services. With a focus on personalized medical solutions, healthcare providers are under pressure to impro

View Source

Similar Deals

CDP Venture Capital Arsenale Bioyards

2025

Seed Stage Biotechnology & Medical Research (NEC) Italy
Utopia SIS PerFormS Srl

2023

Seed Stage Proprietary & Advanced Pharmaceuticals Italy
Claris Ventures ALKemist Bio

2023

Seed Stage Bio Therapeutic Drugs Italy
Utopia SIS and Pariter Partners LighthouseBiotech

2023

Seed Stage Biotechnology & Medical Research (NEC) Italy
a|impact AmaliaCare

2023

Seed Stage Home Healthcare Services Italy

IAG and Doorway

invested in

Rejoint

in 2023

in a Seed Stage deal

Disclosed details

Transaction Size: $1,350M

Deal Parameters
Industry
Country
Seller type

Sign Up to Dealert